Medtech industry experts had predicted the US Food and Drug Administration would reverse the Trump administration’s policy preventing it from regulating
laboratory developed tests (LDT). But eight months after a new administration took the help the policy is still in place -- leaving experts like Sidley Austin’s Coleen Klasmeier scratching their...